Sign up! CNNC BNCT settles in Shandong Cancer Hospital

Sign up! On January eleventh, China National Nuclear Corporation's BNCT settled in Shandong Cancer Hospital. The second Cancer Particle Therapy Conference was grandly held in Jinan, the capital city of China. The conference gathered many top experts in the field of tumor radiotherapy at home and abroad. During the conference, China Tongfu, a subsidiary of China National Nuclear Corporation (CNNC), signed a strategic cooperation agreement with Shandong Cancer Hospital and the establishment of CNNC Particle BNCT at the hospital. The two sides will carry out comprehensive and in-depth cooperation in the fields of nuclear medicine and nuclear medical equipment. This marks a significant breakthrough for China National Nuclear Corporation (CNNC) in the field of cancer treatment equipment, helping Shandong Cancer Hospital become the only hospital in the world with the "three pillars" of proton therapy, heavy ion therapy, and BNCT. Chen Ping, member of the Party Group of Shandong Provincial Government and Vice Governor, Li Guoxiang, member of the Standing Committee of Jinan Municipal Party Committee and Secretary of the Political and Legal Affairs Commission, Xu Min, member of the Party Group and Deputy Director of Shandong Provincial Health Commission, Liu Sijin, Secretary of the Party Committee of Shandong First Medical University (Provincial Academy of Medical Sciences), Zhang Kai, member of the Party Group and Deputy General Manager of China National Nuclear Corporation, Meng Yanbin, Assistant General Manager and Chief Network Security Officer of China National Nuclear Corporation, Han Yongjiang, Deputy Chief Economist of China National Nuclear Corporation, Secretary of the Party Committee and Chairman of China National Nuclear Corporation, and other leaders attended and witnessed the signing of the contract. The person in charge of China Tongfu signed the agreement with Yu Jinming, an academician of the CAE Member and president of Shandong Cancer Hospital. Shandong Cancer Hospital has been ranked first among provincial cancer hospitals for several consecutive years due to its excellent medical technology and scientific research innovation capabilities. As the main force of the national nuclear technology industry and the "chain leader" of the nuclear technology application industry chain, China National Nuclear Corporation (CNNC) has always adhered to the people-centered development concept, regarded maintaining people's health as the highest pursuit, vigorously developed nuclear technology, and used continuous technological innovation as the driving force to promote the research and development of equipment and drugs in fields such as nuclear medicine and radiation therapy. As a specialized nuclear technology application company under China National Nuclear Corporation, China Tongfu has been committed to providing comprehensive solutions for nuclear medicine, radiotherapy, and the promotion and application of radiation technology. This cooperation signing is a concrete manifestation of China Tongfu and Shandong Cancer Hospital actively responding to the national innovation driven development strategy and promoting high-quality development of the medical and health industry. Both parties will work together to explore the "industry university research medical" aggregation ecosystem, fully leverage the advantages of both parties, and promote the clinical application and promotion of BNCT technology. BNCT technology is a rapidly developing binary targeted precision radiotherapy technology in the field of international cancer treatment in recent years. It has outstanding advantages such as high flux of hyperthermic neutron beams, low harmful fast neutron components, and low radiation dose in the treatment room environment. CNNC Particle BNCT Kunboron Knife meets the national strategic demand for high-end medical equipment with independent and controllable capabilities. Multiple technologies have filled the domestic gap, and the technical indicators have reached the leading domestic and international advanced levels. CNNC Particle has successfully won the bid for the BNCT project of Shandong Cancer Hospital, which is another significant achievement after the joint construction of the BNCT Nuclear Medicine Diagnosis and Treatment Demonstration Center project in Bishan District, Chongqing. Dreams may be distant, but they can be achieved through pursuit; Although it may be difficult to make a wish, it can be fulfilled with perseverance. In the great journey of promoting the construction of a strong country and national rejuvenation, China Tongfu will continue to demonstrate the role of China National Nuclear Corporation (CNNC) and contribute its strength, continuously promote the independent and controllable development of high-end nuclear medical equipment, and help build a healthy China. China National Nuclear Corporation Technology Quality and Digitalization Department, Industrial Development and